Metformin Medical Valley

Metformin, the active ingredient in Metformin Medical Valley, is a biguanide presented as an oral tablet for oral use. It is used to improve glycemic control in adults with type 2 diabetes mellitus by reducing hepatic glucose output and enhancing peripheral insulin sensitivity, thereby lowering elevated blood glucose levels.

GNH USA supplies Metformin Medical Valley as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin is indicated for disorders of glucose metabolism and related conditions. - Type 2 diabetes mellitus: improves glycemic control and reduces HbA1c levels. - Prediabetes (impaired fasting glucose): delays progression to type 2 diabetes. - Gestational diabetes mellitus (when diet alone is insufficient): assists in achieving target glucose levels.

Metformin is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, or loss of appetite. - Diarrhea: frequent loose stools, especially during treatment initiation. - Metallic taste: transient alteration in taste perception. - Vitamin B12 deficiency: reduced absorption with long‑term use.

Serious or Rare Side Effects: - Lactic acidosis: a rare but life‑threatening accumulation of lactate. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction: marked elevation of liver enzymes. - Hypoglycemia: when combined with other glucose‑lowering agents. - Pancreatitis: inflammation of the pancreas.

Metformin requires careful patient assessment and monitoring. - Renal function: evaluate eGFR before initiation and periodically thereafter. - Lactic acidosis risk: avoid in patients with severe renal or hepatic impairment. - Alcohol consumption: limit intake as it may increase lactic acidosis risk. - Pregnancy: use only if potential benefit justifies potential risk to the fetus. - Vitamin B12 monitoring: consider periodic assessment during long‑term therapy. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Metformin may interact with several medicines, requiring vigilance.

Major Interactions (Avoid): - Iodinated contrast agents: can precipitate acute renal failure, increasing lactic acidosis risk. - Cimetidine: may raise metformin plasma concentrations. - Alcohol abuse: synergistically raises the risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Sulfonylureas or insulin: increase risk of hypoglycemia. - Beta‑blockers: may mask hypoglycemia symptoms. - Diuretics: can affect renal clearance of metformin.